等待开盘
0.000
NaN.00%
Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 73.58 percent increase over losses of $(1.06) per share from the same period last year.
05-08 19:38
US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0.65%. GM reports better-than-expected Q1 results.
04-29 00:35
US stocks mixed with Dow up 150 pts. Dow up 0.27%, NASDAQ down 1.06%, S&P 500 down 0.52%. Energy shares up 1.7%. Coca-Cola beats earnings & raises guidance. Baiya Int'l up 126%, Nexera up 63%, Aterian up 35%. Soligenix down 64%, Vistance down 51%, Erasca down 49%. Oil up 3.3%, gold down 2.3%, silver down 3.4%, copper down 0.7%. European markets mixed. Asian markets lower. US home prices increase, private-sector jobs report coming.
04-28 21:49
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03122026_SNGX_Bautz.pdf
03-12 22:06
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
03-10 19:35
Gainers Inspira Technologies Oxy (NASDAQ:IINN) shares increased by 25.9% to $0...
02-09 20:05
Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong tolerability.
2025-12-18 02:23
北京时间2025年01月15日04时07分,Terns Pharmaceuticals, Inc.(TERN.us)股票出现异动,股价急速下跌5.00%。截至发稿,该股报4.56美元/股,成交量80.7751万股,换手率0.95%,振幅6.77%。 最近的财报数据显示,该股实现营业收入0.00美元,净利润-21.95百万美元,每股收益-0.28美元,毛利-206000.00美元,市盈率-3.88倍。 机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。 Terns Pharmaceuticals, Inc.股票所在的生物技术行业中,...
2025-01-15 04:07
北京时间2025年01月15日03时53分,莫德纳(MRNA.us)股票出现异动,股价急速跳水5.09%。截至发稿,该股报33.36美元/股,成交量897.038万股,换手率2.33%,振幅6.48%。 最近的财报数据显示,该股实现营业收入18.62亿美元,净利润13.00百万美元,每股收益0.03美元,毛利12.96亿美元,市盈率-5.75倍。 机构评级方面,在所有28家参与评级的机构中,32%的券商给予买入建议,54%的券商给予持有建议,14%的券商给予卖出建议。 莫德纳股票所在的生物技术行业中,整体跌幅为0.86%。其相关个股中,Eterna Therapeutics Inc.、Jasp...
2025-01-15 03:53
北京时间2025年01月15日03时41分,阿里拉姆制药(ALNY.us)股票出现异动,股价大幅下跌5.09%。截至发稿,该股报245.13美元/股,成交量30.4432万股,换手率0.24%,振幅5.43%。 最近的财报数据显示,该股实现营业收入5.01亿美元,净利润-1.12亿美元,每股收益-0.87美元,毛利4.15亿美元,市盈率-93.74倍。 机构评级方面,在所有33家参与评级的机构中,70%的券商给予买入建议,24%的券商给予持有建议,6%的券商给予卖出建议。 阿里拉姆制药股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Eterna Therapeutics Inc....
2025-01-15 03:41